Not meaning to hijack, but this reminds me of some trivia about one of my favorite diseases in medical school: Kawasaki Disease or Syndrome. The following ain’t medical advice no-how. I’m just sharing the kind of tidbit that I imagine the hardcore SDMB’er might find interesting.
Now, it’s a tragic condition, make no mistake, but it’s chock full of quirks that endeared it to me. Woe betide the student who failed to check a toddler rash or or fever for the classic ‘strawberry tongue’! In some cases it can evolve to a sudden dissecting aneurysm, and it’s one of those rare conditions where the old vaudeville joke “Take two aspirin and call me in the morning” could save a life - because ordinary-dose aspirin is actually a primary treatment to prevent the aorta from dissecting
It also happens to support a view I’ve had since they took children’s aspirin off the market. Remember those apricot colored, orange flavored St. Joseph’s Baby aspirins that once had a place in every family medicine cabinet? It was among the safest and most trusted medications for 100 years until an outbreak of Guillain Barre’ syndrome in the late 70’s. Guillain-Barre can present as something as mild as peripheral tingling, but the thing that scared the medical establishment was the possible progression to total paralysis, or even a collapse inheart rate and blood pressure. G-B strikes both sexes and all ages, and is pretty darn rare (1 in 100,000). It usually occurs after a respiratory or gastrointestinal virus, and during the late 70s outbreak, a study showed a link to the use of aspirin during certain viral infections.
Overnight, we all became terrified of giving our children St. Joseph’s. Tylenol (which is also pretty safe, but wasn’t usually given to children over 18 mos back then) took over in pediatric applications. The funny thing is that other countries continued to use baby aspirin with no dire effects, and St. Joseph’s Baby aspirin is now sold over the counter in the US as “coronary strength” aspirin (1/4th the aspirin at 4-10x the price or more) to decrease the risk or damage of heart attacks [even though Guillain Barre strikes all ages fairly equally]
My general impression of the literature from 1978-1992 (the last time I seriously checked) was that the switch from children’s aspirin to children’s acetominophen slightly increased the overall health risk to children. I can’t be absolutely certain because the net risks we’re discussing are in the parts-per-million range, and no one had done -much less repeated- a powerful enough study with millions of child subjects, but recall that the Guillain-Barre Syndrome that so scared us only occurs in 10 cases per million, and wasn’t noticed until aspirin, the most studied drug of all time, had been sold ver the counter for 100 years. The acetominophen which replaced it is known to be more toxic, causes more ‘accidental ingestion’ fatalities in children than aspirin did, and doesn’t help diseases like Kawasaki’s – but only a huge rigorous study could assess all the risks and benefits, and the difference is almost certainly tiny.
There’s no way I’d give kids aspirin for ordinary fevers. The legal standard is ‘prevailing local practice’ and since no other docs do it, I’d be sued out of my skivvies if anything (even an Easter Bunny mauling) happened to the kid afterward. I don’t lose sleep over it, since the risks are small, either way.
But I don’t put on blinders either. As far as aI can tell (and I’d welcome a journal cite of a suitably statistically powerful study from any of the other docs or medical types here), we panicked in response to a rather small risk, and ended up increasing the net risk slightly. Ironic, eh? And you can bet no one’s going to fund the giant study needed to confirm or disprove it (nor should they: the potential improvement would be tiny, and the money for such a large study would be better spent on other conditions/treatments)